Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood

키워드

참고문헌 (65)

1. Grimshaw GM, "Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities", Health Technol Assess, 7, pp.1~146 (2003)
2. Megarbane A, "The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome", Genet Med, 11, pp.611~616 (2009)
3. ACOG Committee on Practice Bulletins, "ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities", Obstet Gynecol, 109, pp.217~227 (2007)
4. Malone FD, "First-trimester or second-trimester screening, or both, for Down’s syndrome", N Engl J Med, 353, pp.2001~2011 (2005)
5. Nicolaides KH, "Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities", Am J Obstet Gynecol, 191, pp.45~67 (2004)
6. Rozenberg P, "Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population", Am J Obstet Gynecol, 195, pp.1379~1387 (2006)
7. American College of Obstetricians and Gynecologists, "ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy", Obstet Gynecol, 110, pp.1459~1467 (2007)
8. Alfirevic Z, "Amniocentesis and chorionic villus sampling for prenatal diagnosis", Cochrane Database Syst Rev, (3), pp.CD003252~ (2003)
9. Cheung MC, "Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood", Nat Genet, 14, pp.264~268 (1996)
10. Rust DW, "Microchimerism in endocrine pathology", Endocr Pathol, 20, pp.11~16 (2009)
11. Bianchi DW, "Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study", Prenat Diagn, 22, pp.609~615 (2002)
12. Lo YM, "Presence of fetal DNA in maternal plasma and serum", Lancet, 350, pp.485~487 (1997)
13. Lun FM, "Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma", Clin Chem, 54, pp.1664~1672 (2008)
14. Lo YM, "Rapid clearance of fetal DNA from maternal plasma", Am J Hum Genet, 64, pp.218~224 (1999)
15. Lo YM, "Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus", Sci Transl Med, 2, pp.61~91 (2010)
16. Scheffer PG, "E and of K in alloimmunised pregnant women : evaluation of a 7-year clinical experience", BJOG, 118, pp.1340~1348 (2011)
17. Young-Ho Yang, "Noninvasive Prenatal Diagnosis using Cell-Free Fetal DNA in Maternal Plasma: Clinical Applications", 대한의학유전학회지, 8(1), pp.1~16 (2011), 대한의학유전학회
18. 류현미, "Effective Method for Extraction of Cell-Free DNA from Maternal Plasma for Non-Invasive First-Trimester Fetal Gender Determination: A Preliminary Study", 대한의학유전학회지, 7(1), pp.53~58 (2010), 대한의학유전학회
19. Go AT, "Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities", Hum Reprod Update, 17, pp.372~382 (2011)
20. Chiu RW, "Non-invasive prenatal diagnosis by single molecule counting technologies", Trends Genet, 25, pp.324~331 (2009)
21. Lo YM, "Digital PCR for the molecular detection of fetal chromosomal aneuploidy", Proc Natl Acad Sci U S A, 104, pp.13116~13121 (2007)
22. Fan HC, "Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood", Proc Natl Acad Sci U S A, 105, pp.16266~16271 (2008)
23. Chiu RW, "Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma", Proc Natl Acad Sci U S A, 105, pp.20458~20463 (2008)
24. Sehnert AJ, "Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood", Clin Chem, 57, pp.1042~1049 (2011)
25. Chiu RW, "Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study", BMJ, 342, pp.c7401~ (2011)
26. Ehrich M, "Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting", Am J Obstet Gynecol, 204, pp.205.e1~205.e11 (2011)
27. Bianchi DW, "Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing", Obstet Gynecol, 119, pp.890~901 (2012)
28. Palomaki GE, "DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study", Genet Med, 14, pp.296~305 (2012)
29. Sparks AB, "Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18", Am J Obstet Gynecol, 206, pp.319.e1~319.e9 (2012)
30. Sparks AB, "Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy", Prenat Diagn, 32, pp.3~9 (2012)
31. (2013)[URL]
32. (2013)[URL]
33. Saito H, "Prenatal DNA diagnosis of a single-gene disorder from maternal plasma", Lancet, 356, pp.1170~ (2000)
34. Tang NL, "Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma", Clin Chem, 45, pp.2033~2035 (1999)
35. Finning K, "Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women : prospective feasibility study", BMJ, 336, pp.816~818 (2008)
36. Lo YM, "Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction", Cancer Res, 59, pp.3899~3903 (1999)
37. Wong IH, "Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients", Cancer Res, 59, pp.71~73 (1999)
38. Esteller M, "Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients", Cancer Res, 59, pp.67~70 (1999)
39. Poon LL, "Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma", Clin Chem, 48, pp.35~41 (2002)
40. Chim SS, "Detection of the placental epigenetic signature of the maspin gene in maternal plasma", Proc Natl Acad Sci U S A, 102, pp.14753~14758 (2005)
41. Chan KC, "Hypermethylated RASSF1A in maternal plasma : A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis", Clin Chem, 52, pp.2211~2218 (2006)
42. Li E, "Role for DNA methylation in genomic imprinting", Nature, 366, pp.362~365 (1993)
43. Driscoll DJ, "A DNA methylation imprint, determined by the sex of the parent, distinguishes the Angelman and Prader-Willi syndromes", Genomics, 13, pp.917~924 (1992)
44. Schneid H, "Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome", J Med Genet, 30, pp.353~362 (1993)
45. Gama-Sosa MA, "Tissue-specific differences in DNA methylation in various mammals", Biochim Biophys Acta, 740, pp.212~219 (1983)
46. Fuke C, "Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas : an HPLC-based study", Ann Hum Genet, 68, pp.196~204 (2004)
47. Maccani MA, "Epigenetics in the placenta", Am J Reprod Immunol, 62, pp.78~89 (2009)
48. Bianchi DW, "Fetal DNA in maternal plasma: the plot thickens and the placental barrier thins", Am J Hum Genet, 62, pp.763~764 (1998)
49. Flori E, "Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report", Hum Reprod, 19, pp.723~724 (2004)
50. Lui YY, "Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation", Clin Chem, 48, pp.421~427 (2002)
51. Frommer M, "A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands", Proc Natl Acad Sci U S A, 89, pp.1827~1831 (1992)
52. Herman JG, "Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands", Proc Natl Acad Sci U S A, 93, pp.9821~9826 (1996)
53. Grunau C, "Bisulfite genomic sequencing: systematic investigation of critical experimental parameters", Nucleic Acids Res, 29, pp.E65~ (2001)
54. Tong YK, "Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach", Clin Chem, 56, pp.90~98 (2010)
55. McClelland M, "Effect of site-specific modification on restriction endonucleases and DNA modification methyltransferases", Nucleic Acids Res, 22, pp.3640~3659 (1994)
56. Weisenberger DJ, "DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight", Nucleic Acids Res, 36, pp.4689~4698 (2008)
57. Li M, "Sensitive digital quantification of DNA methylation in clinical samples", Nat Biotechnol, 27, pp.858~863 (2009)
58. Lim JH, "Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma", PLoS One, 6, pp.e27709~ (2011)
59. Chim SS, "Systematic search for placental DNA-methylation markers on chromosome 21 : toward a maternal plasma-based epigenetic test for fetal trisomy 21", Clin Chem, 54, pp.500~511 (2008)
60. Tong YK, "Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker", PLoS One, 5, pp.e15244~ (2010)
61. Weber M, "Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells", Nat Genet, 37, pp.853~862 (2005)
62. Khulan B, "Comparative isoschizomer profiling of cytosine methylation : the HELP assay", Genome Res, 16, pp.1046~1055 (2006)
63. Down TA, "A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis", Nat Biotechnol, 26, pp.779~785 (2008)
64. Weng YI, "Methylated DNA immunoprecipitation and microarray-based analysis: detection of DNA methylation in breast cancer cell lines", Methods Mol Biol, 590, pp.165~176 (2009)
65. Papageorgiou EA, "Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21", Nat Med, 17, pp.510~513 (2011)

관련 논문AI추천